AA
LLY icon

ACT Advisors’s Eli Lilly LLY Stock Holding History

ACT Advisors’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$465K Buy
387
+38
+11% +$38.8K 0.15% 41
2026
Q1 		$321K Buy
349
+23
+7% +$23.3K 0.14% 52
2025
Q4 		$351K Buy
326
+40
+14% +$38.2K 0.14% 46
2025
Q3 		$218K Sell
286
-38
-12% -$28.3K 0.09% 58
2025
Q2 		$253K Buy
324
+14
+5% +$10.9K 0.12% 47
2025
Q1 		$256K Sell
310
-8
-3% -$6.66K 0.14% 43
2024
Q4 		$246K Buy
318
+40
+14% +$33.1K 0.13% 42
2024
Q3 		$246K Buy
278
+14
+5% +$12.6K 0.12% 40
2024
Q2 		$239K Buy
+264
New +$211K 0.12% 39

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

ACT Advisors's LLY Position: Q2 2026 in Review

ACT Advisors increased its Eli Lilly (LLY) stake by 11% in Q2 2026, buying an estimated $38.8K and bringing the position to 387 shares worth $465K. The position accounts for 0.15% of the portfolio, ranked #41.

ACT Advisors first reported a position in LLY in Q2 2024 and has held it in 9 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • ACT Advisors held 387 shares of Eli Lilly worth $465K as of Q2 2026.
  • ACT Advisors bought 38 Eli Lilly shares in Q2 2026, an estimated $38.8K.
  • Eli Lilly made up 0.15% of ACT Advisors's portfolio in Q2 2026, its #41 holding.
  • ACT Advisors first reported a position in Eli Lilly in Q2 2024 and has held it in 9 quarters since.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on ACT Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.